Polyarticular juvenile idiopathic arthritis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:404580
Who is this for?
Show terms as
5FDA treatments10Specialists8Treatment centers3Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Polyarticular juvenile idiopathic arthritis (polyarticular JIA) is a type of childhood arthritis that affects five or more joints during the first six months of the disease. It is sometimes called polyarticular juvenile rheumatoid arthritis or polyarticular-onset JIA. This condition causes the immune system to mistakenly attack the lining of the joints, leading to inflammation, pain, swelling, and stiffness. It most commonly affects the small joints of the hands and feet, but can also involve the knees, hips, ankles, wrists, and neck. There are two subtypes of polyarticular JIA: rheumatoid factor (RF) positive and RF negative. The RF-positive form behaves more like adult rheumatoid arthritis and tends to be more aggressive. The RF-negative form is more common and may have a more variable course. Children with this condition may experience morning stiffness, fatigue, reduced appetite, and difficulty with everyday activities like writing, walking, or dressing. Treatment has improved significantly over the past two decades. The goal is to control inflammation, prevent joint damage, and help children live active lives. Treatment typically includes nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs) like methotrexate, and biologic therapies such as etanercept, adalimumab, abatacept, and tocilizumab. With early and aggressive treatment, many children achieve remission or significant improvement in their symptoms.

Also known as:

Key symptoms:

Joint pain in five or more jointsJoint swelling and warmthMorning stiffness lasting more than 30 minutesDifficulty moving or bending jointsFatigue and low energyReduced appetite or poor weight gainLow-grade feverLimping or changes in walkingDifficulty with fine motor tasks like writing or buttoning clothesJoint stiffness after sitting or restingEye inflammation (uveitis)Growth problems or uneven limb lengthMuscle weakness around affected jointsIrritability in younger children

Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗NORD ↗

FDA & Trial Timeline

1 event
Sep 2020

SIMPONI ARIA®: FDA approved

treatment of active polyarticular juvenile idiopathic arthritis (pJIA) in patients 2 years of age and older

FDAcompleted

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

5 available

Enbrel

etanercept· Immunex Corporation■ Boxed Warning

indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (pJIA) in patients 2 years of age and older

Orencia

abatacept· Bristol-Myers Squibb Co.

the treatment of patients 2 years of age and older with moderately to severely active polyarticular juvenile idiopathic arthritis (pJIA)

Actemra

tocilizumab· Genentech, Inc.■ Boxed Warning

indicated for the treatment of active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older

HUMIRA

adalimumab· AbbVie, Inc.■ Boxed Warning

Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older

SIMPONI ARIA�

golimumab· Janssen Research & Development, LLC■ Boxed WarningOrphan Drug

treatment of active polyarticular juvenile idiopathic arthritis (pJIA) in patients 2 years of age and older

No actively recruiting trials found for Polyarticular juvenile idiopathic arthritis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Polyarticular juvenile idiopathic arthritis community →

Specialists

10 foundView all specialists →
TK
Takahiro Kakehi
Specialist
PI on 4 active trials1 Polyarticular juvenile idiopathic arthritis publication
YM
Yukiko Kimura, MD
HACKENSACK, NJ
Specialist
PI on 1 active trial
SM
Sarah Ringold, MD
SEATTLE, WA
Specialist
PI on 1 active trial
SP
Shigeki Hashimoto, PhD
Specialist
PI on 1 active trial
PP
Pekka Lahdenne, MD, PhD
Specialist
PI on 1 active trial
MR
Md. Mahbubur Rahman
WILKES BARRE, PA
Specialist
PI on 1 active trial108 Polyarticular juvenile idiopathic arthritis publications
RP
Ragab K Elnaggar, PhD
Specialist
PI on 3 active trials
RP
Radmila Kanceva, MD, PhD
Specialist
PI on 1 active trial
EM
Eunjung Gu, MS
Specialist
PI on 1 active trial
MP
Maged Basha, PhD
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

3 resources
Orencia(abatacept)Bristol-Myers Squibb Co.
Actemra(tocilizumab)Genentech, Inc.
HUMIRA(adalimumab)AbbVie, Inc.

Travel Grants

No travel grants are currently matched to Polyarticular juvenile idiopathic arthritis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Polyarticular juvenile idiopathic arthritisForum →

No community posts yet. Be the first to share your experience with Polyarticular juvenile idiopathic arthritis.

Start the conversation →

Latest news about Polyarticular juvenile idiopathic arthritis

No recent news articles for Polyarticular juvenile idiopathic arthritis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Is my child's polyarticular JIA rheumatoid factor positive or negative, and what does that mean for the long-term outlook?,What treatment plan do you recommend, and what are the potential side effects of these medications?,How often does my child need eye exams to check for uveitis?,What signs should I watch for that would indicate a disease flare or a medication side effect?,Are there any activities my child should avoid, or can they participate in sports and physical education?,What is the likelihood that my child will achieve remission, and could they eventually stop taking medications?,How will this condition be managed as my child grows into a teenager and young adult?

Common questions about Polyarticular juvenile idiopathic arthritis

What is Polyarticular juvenile idiopathic arthritis?

Polyarticular juvenile idiopathic arthritis (polyarticular JIA) is a type of childhood arthritis that affects five or more joints during the first six months of the disease. It is sometimes called polyarticular juvenile rheumatoid arthritis or polyarticular-onset JIA. This condition causes the immune system to mistakenly attack the lining of the joints, leading to inflammation, pain, swelling, and stiffness. It most commonly affects the small joints of the hands and feet, but can also involve the knees, hips, ankles, wrists, and neck. There are two subtypes of polyarticular JIA: rheumatoid fa

How is Polyarticular juvenile idiopathic arthritis inherited?

Polyarticular juvenile idiopathic arthritis follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Polyarticular juvenile idiopathic arthritis typically begin?

Typical onset of Polyarticular juvenile idiopathic arthritis is childhood. Age of onset can vary across affected individuals.

Which specialists treat Polyarticular juvenile idiopathic arthritis?

10 specialists and care centers treating Polyarticular juvenile idiopathic arthritis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Polyarticular juvenile idiopathic arthritis?

3 patient support programs are currently tracked on UniteRare for Polyarticular juvenile idiopathic arthritis. See the treatments and support programs sections for copay assistance, eligibility, and contact details.